You are here » Home » Companies » Company Overview » Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd.

BSE: 524742 Sector: Health care
NSE: CAPLIPOINT ISIN Code: INE475E01026
BSE LIVE 15:42 | 18 Aug 676.45 4.70
(0.70%)
OPEN

661.60

HIGH

688.40

LOW

657.25

NSE 15:46 | 18 Aug 674.80 4.35
(0.65%)
OPEN

664.00

HIGH

687.65

LOW

657.00

OPEN 661.60
PREVIOUS CLOSE 671.75
VOLUME 13697
52-Week high 783.90
52-Week low 235.02
P/E 63.34
Mkt Cap.(Rs cr) 5,114
Buy Price 676.45
Buy Qty 35.00
Sell Price 0.00
Sell Qty 0.00
OPEN 661.60
CLOSE 671.75
VOLUME 13697
52-Week high 783.90
52-Week low 235.02
P/E 63.34
Mkt Cap.(Rs cr) 5,114
Buy Price 676.45
Buy Qty 35.00
Sell Price 0.00
Sell Qty 0.00

Caplin Point Laboratories Ltd. (CAPLIPOINT) - Company History

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.